Scarica l'app Stockscreener
31.25
4.59%
1.37
Dopo l'orario di chiusura:
31.27
0.02
+0.06%
Precedente Chiudi:
$29.88
Aprire:
$29.93
Volume 24 ore:
569.30K
Relative Volume:
1.63
Capitalizzazione di mercato:
$1.32B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+30.78%
1M Prestazione:
+40.77%
6M Prestazione:
+169.86%
1 anno Prestazione:
+47.16%
Intervallo 1D:
$29.88
$31.91
Intervallo di 1 settimana:
$24.20
$34.33
Portata 52W:
$5.83
$34.33
Zenas Biopharma Inc Stock (ZBIO) Company Profile
Nome
Zenas Biopharma Inc
Settore
Industria
Telefono
857-271-2954
Indirizzo
852 WINTER STREET, SUITE 250, WALTHAM
Confronta ZBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBIO
Zenas Biopharma Inc
|
31.25 | 1.41B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-20 | Iniziato | Wedbush | Outperform |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-05 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-08 | Iniziato | Citigroup | Buy |
| 2024-10-08 | Iniziato | Guggenheim | Buy |
| 2024-10-08 | Iniziato | Jefferies | Buy |
| 2024-10-08 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Zenas Biopharma Inc Borsa (ZBIO) Ultime notizie
How to track smart money flows in Zenas BioPharma Inc.Market Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Multi asset correlation models including Zenas BioPharma Inc.Dollar Strength & Community Driven Trade Alerts - newser.com
What dividend safety score for Zenas BioPharma Inc. stock2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Price momentum metrics for Zenas BioPharma Inc. explainedQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
How Zenas BioPharma Inc. stock reacts to inflationary pressuresMarket Growth Review & Low Risk Entry Point Tips - newser.com
Applying chart zones and confluence areas to Zenas BioPharma Inc.Day Trade & Daily Profit Maximizing Tips - newser.com
Has Zenas BioPharma Inc. formed a bullish divergenceTrade Analysis Report & Weekly Momentum Picks - newser.com
Is Zenas BioPharma Inc. stock ready for breakoutQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
Leading vs lagging indicators on Zenas BioPharma Inc. performanceJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
How risky is Zenas BioPharma Inc. stock nowChart Signals & Smart Money Movement Tracker - newser.com
Citigroup Raises Zenas BioPharma (NASDAQ:ZBIO) Price Target to $46.00 - MarketBeat
Zenas BioPharma, Inc.Common Stock (Nasdaq:ZBIO) Stock Quote - FinancialContent
Weiss Ratings Reiterates Sell (E+) Rating for Zenas BioPharma (NASDAQ:ZBIO) - MarketBeat
HC Wainwright Reduces Earnings Estimates for Zenas BioPharma - MarketBeat
Strategies to average down on Zenas BioPharma Inc.Insider Selling & Technical Entry and Exit Tips - newser.com
Published on: 2025-10-31 01:53:58 - newser.com
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7.3%Here's What Happened - MarketBeat
Is Zenas BioPharma Inc a good long term investmentPortfolio Allocation Tips & Free Phenomenal Trading Returns - earlytimes.in
Zenas BioPharma (ZBIO) Price Target Increased by 21.59% to 40.22 - MSN
Promising Phase 2 Results and Strategic Licensing Drive Buy Rating for Zenas BioPharma - TipRanks
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
How to build a dashboard for Zenas BioPharma Inc. stockEarnings Recap Summary & Growth Focused Stock Reports - newser.com
Zenas BioPharma (NASDAQ:ZBIO) Given Outperform Rating at Wedbush - MarketBeat
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
HC Wainwright & Co. Maintains Zenas BioPharma (ZBIO) Buy Recommendation - MSN
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap UpWhat's Next? - MarketBeat
1 Trial, 2 Franchises: Zenas Stock Climbs on Landmark Data - sharewise.com
ZBIO: Citigroup Raises Price Target, Maintains Buy Rating | ZBIO Stock News - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Stockholders to Reach Out - ACCESS Newswire
ZBIO: Morgan Stanley Raises Price Target, Maintains Overweight R - GuruFocus
Zenas BioPharma, Inc. (ZBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incyte trims pipeline; Zenas surges on MS drug results - BioPharma Dive
ZBIO: HC Wainwright & Co. Raises Price Target, Maintains 'Buy' R - GuruFocus
Zenas’ bifunctional mAb scores at Phase II in relapsing MS - Yahoo Finance
Zenas Biopharma stock reaches all-time high at 29.73 USD By Investing.com - Investing.com Australia
Zenas BioPharma (NASDAQ:ZBIO) Reaches New 12-Month HighTime to Buy? - MarketBeat
Zenas Biopharma Inc Azioni (ZBIO) Dati Finanziari
Non sono disponibili dati finanziari per Zenas Biopharma Inc (ZBIO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):